rivastigmine tartrate 4.5 MG Oral Capsule
- RxCUI
- 314215
- RxNorm name
- rivastigmine tartrate 4.5 MG Oral Capsule
- Display name
- rivastigmine tartrate 4.5 MG Oral Capsule
- Full name
- rivastigmine tartrate 4.5 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Aurobindo Pharma Limited | c246a0e5-1e77-41ee-a7b3-384f21f2f2e0 | 2024-06-19 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Chartwell RX, LLC | 2bb5e0d6-f677-4021-9888-3ff90979ef7d | 2023-10-06 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Alembic Pharmaceuticals Limited | 33e6a772-382d-45f5-9d45-966c07759367 | 2023-01-16 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Cadila Pharmaceuticals Limited | e7e641fe-39bd-4681-a430-6dedeb6d6af5 | 2022-12-29 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Modavar Pharmaceuticals LLC | 209f3b02-0acf-46e9-b355-91c918a20eb3 | 2022-12-28 | Warnings, Adverse reactions | 314215 |
| RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | Macleods Pharmaceuticals Limited | 4364f6ef-a8da-4805-be0d-aabbe8ca2d21 | 2022-08-24 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Alembic Pharmaceuticals Inc. | 0044f1d7-613c-4611-8481-13032c8cb390 | 2022-03-21 | Warnings, Adverse reactions | 314215 |
| RIVASTIGMINE TARTRATE | RIVASTIGMINE TARTRATE | Nivagen Pharmaceuticals, Inc. | 83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1 | 2022-02-16 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Sun Pharmaceutical Industries, Inc. | bac9ca81-db70-41aa-82af-6c5bb8496846 | 2019-01-31 | Warnings, Adverse reactions | 314215 |
| Rivastigmine Tartrate | RIVASTIGMINE TARTRATE | Dr. Reddy's Laboratories Limited | 0e20124c-725a-0145-996c-2ff908703162 | 2019-01-23 | Warnings, Adverse reactions | 314215 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c246a0e5-1e77-41ee-a7b3-384f21f2f2e0 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 9 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20240619 |
| c246a0e5-1e77-41ee-a7b3-384f21f2f2e0 | rivastigmine 4.5 MG Oral Capsule | SCD | 9 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20240619 |
| c246a0e5-1e77-41ee-a7b3-384f21f2f2e0 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 9 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20240619 |
| 0e20124c-725a-0145-996c-2ff908703162 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 9 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20190123 |
| 0e20124c-725a-0145-996c-2ff908703162 | rivastigmine 4.5 MG Oral Capsule | SCD | 9 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20190123 |
| 0e20124c-725a-0145-996c-2ff908703162 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 9 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20190123 |
| bac9ca81-db70-41aa-82af-6c5bb8496846 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 8 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20190131 |
| bac9ca81-db70-41aa-82af-6c5bb8496846 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 8 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20190131 |
| bac9ca81-db70-41aa-82af-6c5bb8496846 | rivastigmine 4.5 MG Oral Capsule | SCD | 8 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20190131 |
| 4364f6ef-a8da-4805-be0d-aabbe8ca2d21 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 7 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES . RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20220824 |
| 4364f6ef-a8da-4805-be0d-aabbe8ca2d21 | rivastigmine 4.5 MG Oral Capsule | SCD | 7 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES . RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20220824 |
| 4364f6ef-a8da-4805-be0d-aabbe8ca2d21 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 7 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES . RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20220824 |
| 3d257f22-b504-4707-9b29-5ce9032667ca | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 7 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE tartrate capsules, for oral use Initial U.S. Approval: 2000 | 20180219 |
| 3d257f22-b504-4707-9b29-5ce9032667ca | rivastigmine 4.5 MG Oral Capsule | SCD | 7 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE tartrate capsules, for oral use Initial U.S. Approval: 2000 | 20180219 |
| 3d257f22-b504-4707-9b29-5ce9032667ca | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 7 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE tartrate capsules, for oral use Initial U.S. Approval: 2000 | 20180219 |
| e7e641fe-39bd-4681-a430-6dedeb6d6af5 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 6 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20221229 |
| e7e641fe-39bd-4681-a430-6dedeb6d6af5 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 6 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20221229 |
| e7e641fe-39bd-4681-a430-6dedeb6d6af5 | rivastigmine 4.5 MG Oral Capsule | SCD | 6 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20221229 |
| 33e6a772-382d-45f5-9d45-966c07759367 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 3 | These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use. Initial U.S. Approval: 2000 | 20230116 |
| 33e6a772-382d-45f5-9d45-966c07759367 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use. Initial U.S. Approval: 2000 | 20230116 |
| 33e6a772-382d-45f5-9d45-966c07759367 | rivastigmine 4.5 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use. Initial U.S. Approval: 2000 | 20230116 |
| 83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1 | rivastigmine 4.5 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20220216 |
| 83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20220216 |
| 83bd2ff6-1d8b-4cac-a37b-fd01dc3f34a1 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 3 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20220216 |
| 2bb5e0d6-f677-4021-9888-3ff90979ef7d | rivastigmine 4.5 MG Oral Capsule | SCD | 2 | Rivastigmine Tartrate Capsules, USP These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES, USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES, USP. RIVASTIGMINE tartrate capsules, USP for oral use Initial U.S. Approval: 2000 | 20231006 |
| 2bb5e0d6-f677-4021-9888-3ff90979ef7d | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 2 | Rivastigmine Tartrate Capsules, USP These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES, USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES, USP. RIVASTIGMINE tartrate capsules, USP for oral use Initial U.S. Approval: 2000 | 20231006 |
| 2bb5e0d6-f677-4021-9888-3ff90979ef7d | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 2 | Rivastigmine Tartrate Capsules, USP These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES, USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES, USP. RIVASTIGMINE tartrate capsules, USP for oral use Initial U.S. Approval: 2000 | 20231006 |
| 209f3b02-0acf-46e9-b355-91c918a20eb3 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20221228 |
| 209f3b02-0acf-46e9-b355-91c918a20eb3 | rivastigmine 4.5 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20221228 |
| 209f3b02-0acf-46e9-b355-91c918a20eb3 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES USP. RIVASTIGMINE TARTRATE capsules for oral use Initial U.S. Approval: 2000 | 20221228 |
| 0044f1d7-613c-4611-8481-13032c8cb390 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20220321 |
| 0044f1d7-613c-4611-8481-13032c8cb390 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 1 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20220321 |
| 0044f1d7-613c-4611-8481-13032c8cb390 | rivastigmine 4.5 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE TARTRATE capsules, for oral use Initial U.S. Approval: 2000 | 20220321 |
| fead084a-a376-4d57-bdf0-aa7ed3655505 | rivastigmine tartrate 4.5 MG Oral Capsule | PSN | 1 | 20100609 | |
| fead084a-a376-4d57-bdf0-aa7ed3655505 | rivastigmine 4.5 MG Oral Capsule | SCD | 1 | 20100609 | |
| fead084a-a376-4d57-bdf0-aa7ed3655505 | rivastigmine 4.5 MG (as rivastigmine tartrate) Oral Capsule | SY | 1 | 20100609 |